A closer look at the spreaders of COVID-19 in Wisconsin and the US

被引:0
|
作者
Scott, Sherry E. [1 ]
Cook, Keisha J. [2 ]
Barley, Kamal [3 ]
机构
[1] MSOE, Dept Math, Milwaukee, WI USA
[2] Tulane Univ, Dept Math, New Orleans, LA 70118 USA
[3] SUNY Stony Brook, Appl Math & Stat, Stony Brook, NY 11794 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
COVID-19; symptomatic infectious; asymptomatic infectious; pre-symptomatic infectious; natural herd immunity;
D O I
10.3934/mbe.2021188
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this study, we design and use a mathematical model to primarily address the question of who are the main drivers of COVID-19 -the symptomatic infectious or the pre-symptomatic and asymptomatic infectious in the state of Wisconsin and the entire United States. To set the stage, we first briefly simulate and illustrate the benefit of lockdown. With these lockdown scenarios, and in general, the more dominant influence of the the pre-symptomatic and asymptomatic infectious over the symptomatic infectious, is shown in various ways. Numerical simulations for the U.S. show that an increase in testing and isolating for the pre-symptomatic and asymptomatic infectious group has up to 4 times more impact than an increase in testing for the symptomatic infectious in terms of cumulative deaths. An increase in testing for the pre-symptomatic and asymptomatic infectious group also has significantly more impact (on the order of twice as much) on reducing the control reproduction number than testing for symptomatic infectious. Lastly, we use our model to simulate an implementation of a natural herd immunity strategy for the entire U.S. and for the state of Wisconsin (once an epicenter for COVID-19). These simulations provide specific examples confirming that such a strategy requires a significant number of deaths before immunity is achieved, and as such, this strategy is certainly questionable in terms of success.
引用
收藏
页码:3733 / 3754
页数:22
相关论文
共 50 条
  • [1] COVID-19: A Closer Look
    Saljoughian, Manouchehr
    [J]. US PHARMACIST, 2021, 46 (04) : 4 - 7
  • [2] COVID-19: A Closer Look at the MENABanking Sector
    Jreisat, Ammar
    Rabbani, Mustafa Raz A.
    Hatamleh, Zaydoon Mohammad
    Grewal, Himani
    [J]. 2021 INTERNATIONAL CONFERENCE ON DECISION AID SCIENCES AND APPLICATION (DASA), 2021,
  • [3] COVID-19 vaccines-A closer look
    Passi, Gouri Rao
    [J]. INDIAN PEDIATRICS, 2021, 58 (01) : 98 - 98
  • [4] COVID-19 and the kidney: time to take a closer look
    Vassilios Liakopoulos
    Stefanos Roumeliotis
    Stella Papachristou
    Nikolaos Papanas
    [J]. International Urology and Nephrology, 2022, 54 : 1053 - 1057
  • [5] COVID-19 and the kidney: time to take a closer look
    Liakopoulos, Vassilios
    Roumeliotis, Stefanos
    Papachristou, Stella
    Papanas, Nikolaos
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (05) : 1053 - 1057
  • [6] A Closer Look at COVID-19 Patients Outcome by BMI
    Leong, Alfred
    Hosain, Batool
    Li, Hong
    Bjork, Sarah
    Usta, Soeb
    DeSantis, Vincent
    Noginskiy, Ilya
    He, Harvey
    [J]. OBESITY, 2020, 28 : 41 - 41
  • [7] Taking a Closer Look at COVID-19, Health Inequities, and Racism
    Abbasi, Jennifer
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (05): : 427 - 429
  • [8] Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic
    Taha, Huda R.
    Keewan, Nour
    Slati, Farah
    Al-Sawalha, Nour A.
    [J]. PHARMACOLOGY, 2021, 106 (9-10) : 462 - 468
  • [9] Liver Injury in Severe COVID-19 Disease: Need a Closer Look!
    Jindal, Ankur
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (10) : 2218 - +
  • [10] COVID-19: A Closer Lens
    Green-Laughlin, DeLyndia
    [J]. ISSUES IN MENTAL HEALTH NURSING, 2020, 41 (08) : 662 - 664